Comparison of FISH and quantitative RT-PCR for the diagnosis and follow-up of BCR-ABL-positive leukemias (Q80810338)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705578%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Comparison of FISH and quantitative RT-PCR for the diagnosis and follow-up of BCR-ABL-positive leukemias (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705578%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Fei Bao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705578%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Reinhold Munker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705578%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Clarissa Lowery

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705578%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sherry Martin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705578%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Runhua Shi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705578%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Diana M Veillon

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705578%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

James D Cotelingam

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705578%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Mary Lowery Nordberg

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705578%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705578%20AND%20SRC:MED&resulttype=core&format=json

Molecular Diagnosis and Therapy

3 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705578%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705578%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705578%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

239-245

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17705578%20AND%20SRC:MED&resulttype=core&format=json

Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Tra

3 January 2020

cites work

1 reference

12 December 2020

Fluorescent in situ hybridization in the diagnosis, prognosis, and treatment monitoring of chronic myeloid leukemia

1 reference

12 December 2020

The effect of total-ABL, GUS and B2M control genes on BCR-ABL monitoring by real-time RT-PCR.

1 reference

12 December 2020

Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemia

1 reference

12 December 2020

Monitoring minimal residual disease in BCR-ABL-positive chronic myeloid leukemia in the imatinib era.

1 reference

12 December 2020

Interferon-alfa-based treatment of chronic myeloid leukemia and implications of signal transduction inhibition

1 reference

12 December 2020

The development of imatinib as a therapeutic agent for chronic myeloid leukemia

1 reference

12 December 2020

Cytogenetic and fluorescence in situ hybridization monitoring in Ph+ Chronic Myeloid Leukemia patients treated with imatinib mesylate.

1 reference

12 December 2020

Chronic myeloid leukemia

1 reference

12 December 2020

Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients

1 reference

12 December 2020

Interphase cytogenetics and competitive RT-PCR for residual disease monitoring in patients with chronic myeloid leukaemia during interferon-alpha therapy

1 reference

12 December 2020

Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.

1 reference

12 December 2020

Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate

1 reference

12 December 2020

Assessment of the response to imatinib in chronic myeloid leukemia patients--comparison between the FISH, multiplex and RT-PCR methods.

1 reference

12 December 2020

ABL kinase inhibitor therapy for CML: baseline assessments and response monitoring

1 reference

12 December 2020

Progress and challenges in the therapy of adult acute lymphoblastic leukemia.

1 reference

12 December 2020

Comprehensive comparison of FISH, RT-PCR, and RQ-PCR for monitoring the BCR-ABL gene after hematopoietic stem cell transplantation in CML.

1 reference

12 December 2020

Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-alpha therapy or allogeneic bone marrow transplantation

1 reference

12 December 2020

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

1 reference

12 December 2020